LHDXQ — Lucira Health Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$10.36m
- $93.06m
Annual cashflow statement for Lucira Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -6.54 | -8.47 | -37.3 | -64.8 |
| Depreciation | ||||
| Non-Cash Items | 0.645 | 1.3 | 8.31 | 17.5 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.823 | -0.178 | -3.77 | -57.2 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -6.46 | -7.06 | -32.5 | -101 |
| Capital Expenditures | -0.146 | -0.075 | -18.8 | -15.4 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.146 | -0.075 | -18.8 | -15.4 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 3.78 | 11.1 | 108 | 162 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -2.83 | 4 | 56.5 | 45.4 |